All Stories

  1. In Silico Study of Molecular Docking Between Lactoferrin and Autophagy‐apoptosis Genes ATG3, ATG5, and ATG12 and In Vitro Study of Lactoferrin Effect on These Gene Expressions in Breast Cancer
  2. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
  3. MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells
  4. In-silico identification and functional analysis of high-risk oncogenic nsSNPs in the human SDHB gene and their implications for cancer susceptibility
  5. Thymoquinone Upregulates microRNA-199a-3p and Downregulates COX-2 Expression and PGE2 Production via Deactivation of p38/ERK/JNK-MAPKs and p65/p50-NF-κB Signaling in Human Lung Cancer Cells
  6. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  7. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  8. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  9. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  10. Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021
  11. GBD 2023 Cardiovascular Disease Collaborators
  12. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  13. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  14. Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  15. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  16. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  17. Comprehensive Review on Groundwater Exploitation, Depletion, and Its Management: Sustainable Approach Toward Agricultural Productivity in India
  18. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
  19. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  20. Deciphering the Intricacies of Breast Cancer Signaling Network and the Potential of Soy-derived Isoflavones on Cancer Therapeutics
  21. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  22. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  23. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  24. Micro-nano Plastics: Impact on Gastrointestinal System
  25. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  26. The Global Burden of Diarrheal Diseases: Causes, Risks, and Trends (1990–2021)
  27. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  28. Fermentation of soymilk with Lactobacillus acidophilus enhances the functional attributes and health-promoting properties
  29. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  30. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  31. Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis
  32. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
  33. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  34. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
  35. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  36. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  37. Burden of disease scenarios for 204 countries
  38. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  39. Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019
  40. Cold‐active microbial enzymes and their biotechnological applications
  41. Correction to: De novo transcriptome sequencing of drought tolerance–associated genes in little millet (Panicum sumatrense L.)
  42. Food Safety
  43. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  44. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  45. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  46. Physicochemical Characteristics and Antioxidant Activity of Some Algerian Extra Virgin Olive Oils (Olea europaea L.)
  47. Food Safety
  48. Microbial Pigments
  49. Implications of Asymptomatic Carriers for Tuberculosis Transmission and Control in Thailand: A Modelling Approach
  50. Microbial Vitamins and Carotenoids in Food Biotechnology
  51. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  52. National and subnational burden of leukemia and its risk factors, 1990–2019: Results from the Global Burden of Disease study 2019
  53. Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings
  54. Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019
  55. Advanced Food Waste Valorization Techniques for Bioenergy Production: A Path in the Direction of Environmental Sustainability
  56. Sensitivity and Selectivity Between Test Gases in Set (1) LPG, Ethanol, and Acetone and Set (2) NH3, Methanol, and NO2 of BaTiO3/Ag/WO3 Nanocomposite
  57. Selectivity of an Ag/BTO-Based Nanocomposite as a Gas Sensor Between NO2 and SO2 Gases
  58. Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990–2019
  59. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  60. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  61. The national trend of the burden of Chronic Kidney Disease (CKD) in Iran from 1990 to 2019
  62. De novo transcriptome sequencing of drought tolerance–associated genes in little millet (Panicum sumatrense L.)
  63. The levels and trends of metabolic risk factors in the elderly population at the national and sub-national scale in Iran from 1990 to 2016
  64. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
  65. Particulate Matter Pollution Remains a Threat for Cardiovascular Health: Findings From the Global Burden of Disease 2019
  66. Structure-Based Multi-Targeted Molecular Docking and Dynamic Simulation of Soybean-Derived Isoflavone Genistin as a Potential Breast Cancer Signaling Proteins Inhibitor
  67. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  68. Electrochemical biosensors in healthcare services: bibliometric analysis and recent developments
  69. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  70. Diabetes: a defining disease of the 21st century
  71. Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990–2019
  72. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
  73. Inferences on bioengineering perspectives and circular economy to tackle the emerging pollutants
  74. Hormesis-tempting stressors driven by evolutionary factors for mitigating negative impacts instigated over extended exposure to chemical elements
  75. Unlocking the microbial studies through computational approaches: how far have we reached?
  76. Advancements in the energy-efficient brine mining technologies as a new frontier for renewable energy
  77. Myconanotechnology and Application of Nanoparticles in Biology
  78. Value-Addition in Agri-food Industry Waste Through Enzyme Technology
  79. Value-Addition in Beverages through Enzyme Technology
  80. Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019
  81. Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019
  82. Nanotechnology for Nanophytopathogens: From Detection to the Management of Plant Viruses
  83. Integrated biorefinery development for pomegranate peel: Prospects for the production of fuel, chemicals and bioactive molecules
  84. MD Simulation Studies for Selective Phytochemicals as Potential Inhibitors against Major Biological Targets of Diabetic Nephropathy
  85. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
  86. Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
  87. Giardia lamblia infection and associated risk factors among patients attending Kochore Health Center, Ethiopia
  88. Knowledge, Attitude, and Practice of Community towards an Onchocerciasis Elimination Program from South West Ethiopia
  89. Bacterial bioactive metabolites as therapeutic agents: From production to action
  90. Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
  91. Nanocellulose in tissue engineering and bioremediation: mechanism of action
  92. The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990–2019
  93. Editorial: Computational Genomics and Structural Bioinformatics in Microbial Science
  94. Identifying the alpha-glucosidase inhibitory potential of dietary phytochemicals against diabetes mellitus type 2 via molecular interactions and dynamics simulation
  95. Identifying Natural Therapeutics against Diabetes via Inhibition of Dipeptidyl Peptidase 4: Molecular Docking and MD Simulation Study
  96. Molecular Diagnosis, Antimicrobial Resistance Profiles and Disease Patterns of Gram-Positive Pathogens Recovered from Clinical Infections in Major Ha’il Hospitals
  97. Prevalence and Associated Risk Factors of Entamoeba Histolytica Infection Among Schoolchildren From Three Primary Schools In Arsi Town, West Zone, Ethiopia
  98. Microbial Extremozymes
  99. Front Matter
  100. Global impact of trace non-essential heavy metal contaminants in industrial cannabis bioeconomy
  101. Exploring the therapeutic potential of marine-derived bioactive compounds against COVID-19
  102. Assessment of bio-contaminants during COVID-19 outbreak from the indoor environment of Hail city, Kingdom of Saudi Arabia
  103. Interactions of linagliptin, rabeprazole sodium, and their formed complex with bovine serum albumin: Computational docking and fluorescence spectroscopic methods
  104. Prevalence and Risk Factor of Gastro-esophageal Reflux Disease among Hail Population, Saudi Arabia
  105. COLD-ACTIVE MICROBIAL CELLULASE: NOVEL APPROACH TO UNDERSTAND MECHANISM AND ITS APPLICATIONS IN FOOD AND BEVERAGES INDUSTRY
  106. Bioplastics for Sustainable Development
  107. Association between Human Health and Indoor Air Pollution in Saudi Arabia: Indoor Environmental Quality Survey
  108. Enzymatic potential for the valorization of agro-industrial by-products
  109. ELECTROCHEMICAL BIOSENSOR FOR FOOD BORNE PATHOGENS: AN OVERVIEW
  110. Modelling the transmission dynamics of COVID-19 in six high burden countries
  111. Green Nanomaterials for Wastewater Treatment
  112. Degradation of Organic Compounds by the Applications of Metal Nanocomposites
  113. Evaluation of vegetables and fish oils for the attenuation of diabetes complications
  114. Enzymes in Food Biotechnology
  115. A novel, thermotolerant, extracellular PHB depolymerase producer Paenibacillus alvei PHB28 for bioremediation of biodegradable plastics
  116. Enzymes in Food Technology
  117. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics
  118. Enzymatic degradation of PHB
  119. Bioremediation of bioplastics
  120. Oxidative stress and cholinesterase depression among farm workers occupationally exposed to pesticides in India
  121. Strain improvement studies on Microbacterium foliorum GA2 for production of α-amylase in solid state fermentation: Biochemical characteristics and wash performance analysis at low temperatures
  122. Statistical optimization of cold-active chitinase production by mutagenized cells of multi-enzyme producing Bacillus cereus GA6
  123. Production of C-phycocyanin and its potential applications
  124. Bio-statistical approach for optimization of cold-active α-amylase production by novel psychrotolerant M. foliorum GA2 in solid state fermentation
  125. Production of laccase from newly isolated Pseudomonas putida and its application in bioremediation of synthetic dyes and industrial effluents
  126. Isolation of novel chitinolytic bacteria and production optimization of extracellular chitinase
  127. Seasonal variations in cholinesterase activity, nerve conduction velocity and lung function among sprayers exposed to mixture of pesticides
  128. Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition
  129. Cannabis sativa: An ancient wild edible plant of India
  130. Recent Developments in Production and Biotechnological Applications of C-Phycocyanin
  131. Trans-resveratrol restores the damages induced by organophosphate pesticide-monocrotophos in neuronal cells
  132. Visual disturbances with cholinesterase depletion due to exposure of agricultural pesticides among farm workers
  133. Recent developments in production and biotechnological applications of cold-active microbial proteases
  134. Cold-active extracellular α-amylase production from novel bacteria Microbacterium foliorum GA2 and Bacillus cereus GA6 isolated from Gangotri glacier, Western Himalaya
  135. Structural adaptation and biocatalytic prospective of microbial cold-active α-amylase
  136. Cholinesterase levels and morbidity in pesticide sprayers in North India
  137. Production optimization of an extracellular cold-active alkaline protease from Stenotrophomonas maltophilia MTCC 7528 and its application in detergent industry
  138. An Overview of Cold-active Microbial α-amylase: Adaptation Strategies and Biotechnological Potentials
  139. Nerve conduction studies in sprayers occupationally exposed to mixture of pesticides in a mango plantation at Lucknow, North India
  140. Cold-active extracellular alkaline protease from an alkaliphilicStenotrophomonas maltophilia: production of enzyme and its industrial applications
  141. A cold-active extracellular metalloprotease from Curtobacterium luteum (MTCC 7529): Enzyme production and characterization